CN1947778A - 一种具有降血糖作用的药物制剂及其制备方法 - Google Patents
一种具有降血糖作用的药物制剂及其制备方法 Download PDFInfo
- Publication number
- CN1947778A CN1947778A CN 200610138615 CN200610138615A CN1947778A CN 1947778 A CN1947778 A CN 1947778A CN 200610138615 CN200610138615 CN 200610138615 CN 200610138615 A CN200610138615 A CN 200610138615A CN 1947778 A CN1947778 A CN 1947778A
- Authority
- CN
- China
- Prior art keywords
- selenium
- time
- water
- weight portion
- yeast rich
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000003814 drug Substances 0.000 title claims abstract description 47
- 238000000034 method Methods 0.000 title claims abstract description 24
- 230000002218 hypoglycaemic effect Effects 0.000 title claims abstract description 14
- 238000002360 preparation method Methods 0.000 title claims description 9
- 240000004808 Saccharomyces cerevisiae Species 0.000 claims abstract description 39
- 235000005035 Panax pseudoginseng ssp. pseudoginseng Nutrition 0.000 claims abstract description 26
- 235000003140 Panax quinquefolius Nutrition 0.000 claims abstract description 26
- 235000008434 ginseng Nutrition 0.000 claims abstract description 26
- VYZAMTAEIAYCRO-UHFFFAOYSA-N Chromium Chemical compound [Cr] VYZAMTAEIAYCRO-UHFFFAOYSA-N 0.000 claims abstract description 11
- 239000011651 chromium Substances 0.000 claims abstract description 11
- 229910052804 chromium Inorganic materials 0.000 claims abstract description 11
- 239000000284 extract Substances 0.000 claims abstract description 11
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 56
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 54
- BUGBHKTXTAQXES-UHFFFAOYSA-N Selenium Chemical compound [Se] BUGBHKTXTAQXES-UHFFFAOYSA-N 0.000 claims description 48
- 239000011669 selenium Substances 0.000 claims description 48
- 229910052711 selenium Inorganic materials 0.000 claims description 48
- 239000008187 granular material Substances 0.000 claims description 44
- 229940046374 chromium picolinate Drugs 0.000 claims description 38
- GJYSUGXFENSLOO-UHFFFAOYSA-N chromium;pyridine-2-carboxylic acid Chemical compound [Cr].OC(=O)C1=CC=CC=N1.OC(=O)C1=CC=CC=N1.OC(=O)C1=CC=CC=N1 GJYSUGXFENSLOO-UHFFFAOYSA-N 0.000 claims description 38
- 239000000843 powder Substances 0.000 claims description 28
- 229940079593 drug Drugs 0.000 claims description 26
- 241000208340 Araliaceae Species 0.000 claims description 25
- 239000009636 Huang Qi Substances 0.000 claims description 24
- 239000006071 cream Substances 0.000 claims description 16
- 239000000796 flavoring agent Substances 0.000 claims description 9
- 235000019634 flavors Nutrition 0.000 claims description 9
- 239000000203 mixture Substances 0.000 claims description 9
- 229920001353 Dextrin Polymers 0.000 claims description 8
- 239000004375 Dextrin Substances 0.000 claims description 8
- UEDUENGHJMELGK-HYDKPPNVSA-N Stevioside Chemical compound O([C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1O[C@]12C(=C)C[C@@]3(C1)CC[C@@H]1[C@@](C)(CCC[C@]1([C@@H]3CC2)C)C(=O)O[C@H]1[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O1)O)[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O UEDUENGHJMELGK-HYDKPPNVSA-N 0.000 claims description 8
- 235000019425 dextrin Nutrition 0.000 claims description 8
- 239000000706 filtrate Substances 0.000 claims description 8
- 238000002156 mixing Methods 0.000 claims description 8
- 239000000047 product Substances 0.000 claims description 8
- 229940013618 stevioside Drugs 0.000 claims description 8
- OHHNJQXIOPOJSC-UHFFFAOYSA-N stevioside Natural products CC1(CCCC2(C)C3(C)CCC4(CC3(CCC12C)CC4=C)OC5OC(CO)C(O)C(O)C5OC6OC(CO)C(O)C(O)C6O)C(=O)OC7OC(CO)C(O)C(O)C7O OHHNJQXIOPOJSC-UHFFFAOYSA-N 0.000 claims description 8
- 235000019202 steviosides Nutrition 0.000 claims description 8
- 239000006228 supernatant Substances 0.000 claims description 8
- 238000001291 vacuum drying Methods 0.000 claims description 8
- 239000000080 wetting agent Substances 0.000 claims description 8
- 239000000825 pharmaceutical preparation Substances 0.000 claims description 7
- 239000002994 raw material Substances 0.000 claims 1
- 239000000463 material Substances 0.000 abstract description 3
- 230000008569 process Effects 0.000 abstract description 3
- 244000131316 Panax pseudoginseng Species 0.000 abstract 1
- 241000219780 Pueraria Species 0.000 abstract 1
- 240000007164 Salvia officinalis Species 0.000 abstract 1
- 229940107666 astragalus root Drugs 0.000 abstract 1
- 239000002245 particle Substances 0.000 abstract 1
- 235000005412 red sage Nutrition 0.000 abstract 1
- 239000008280 blood Substances 0.000 description 41
- 210000004369 blood Anatomy 0.000 description 40
- 206010012601 diabetes mellitus Diseases 0.000 description 36
- NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical compound N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 description 35
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 21
- 239000008103 glucose Substances 0.000 description 21
- 102000004877 Insulin Human genes 0.000 description 17
- 108090001061 Insulin Proteins 0.000 description 17
- 229940125396 insulin Drugs 0.000 description 17
- 239000006187 pill Substances 0.000 description 17
- 230000035922 thirst Effects 0.000 description 16
- 241001465754 Metazoa Species 0.000 description 15
- 241000699670 Mus sp. Species 0.000 description 13
- 241000283973 Oryctolagus cuniculus Species 0.000 description 12
- 230000000694 effects Effects 0.000 description 12
- 230000037396 body weight Effects 0.000 description 10
- 238000002474 experimental method Methods 0.000 description 9
- 241000699666 Mus <mouse, genus> Species 0.000 description 8
- 210000002784 stomach Anatomy 0.000 description 8
- 201000001421 hyperglycemia Diseases 0.000 description 7
- 238000010791 quenching Methods 0.000 description 7
- 210000002966 serum Anatomy 0.000 description 7
- 210000001124 body fluid Anatomy 0.000 description 6
- 239000010839 body fluid Substances 0.000 description 6
- 235000005911 diet Nutrition 0.000 description 6
- 201000010099 disease Diseases 0.000 description 6
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 6
- 210000000056 organ Anatomy 0.000 description 6
- 241000700159 Rattus Species 0.000 description 5
- 210000004100 adrenal gland Anatomy 0.000 description 5
- 230000006870 function Effects 0.000 description 5
- 230000002496 gastric effect Effects 0.000 description 5
- 210000002216 heart Anatomy 0.000 description 5
- 238000001802 infusion Methods 0.000 description 5
- 210000003734 kidney Anatomy 0.000 description 5
- 210000004072 lung Anatomy 0.000 description 5
- 208000007241 Experimental Diabetes Mellitus Diseases 0.000 description 4
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 4
- HIMXGTXNXJYFGB-UHFFFAOYSA-N alloxan Chemical compound O=C1NC(=O)C(=O)C(=O)N1 HIMXGTXNXJYFGB-UHFFFAOYSA-N 0.000 description 4
- 230000037213 diet Effects 0.000 description 4
- 230000002124 endocrine Effects 0.000 description 4
- 210000004153 islets of langerhan Anatomy 0.000 description 4
- 210000004185 liver Anatomy 0.000 description 4
- 230000007774 longterm Effects 0.000 description 4
- 241000721047 Danaus plexippus Species 0.000 description 3
- 230000009471 action Effects 0.000 description 3
- 210000000227 basophil cell of anterior lobe of hypophysis Anatomy 0.000 description 3
- 210000004027 cell Anatomy 0.000 description 3
- 230000007812 deficiency Effects 0.000 description 3
- 206010013781 dry mouth Diseases 0.000 description 3
- 210000005036 nerve Anatomy 0.000 description 3
- 230000036285 pathological change Effects 0.000 description 3
- 230000000171 quenching effect Effects 0.000 description 3
- 238000011160 research Methods 0.000 description 3
- 210000000952 spleen Anatomy 0.000 description 3
- 239000000725 suspension Substances 0.000 description 3
- 208000024891 symptom Diseases 0.000 description 3
- 238000012360 testing method Methods 0.000 description 3
- 210000002700 urine Anatomy 0.000 description 3
- WSFSSNUMVMOOMR-UHFFFAOYSA-N Formaldehyde Chemical compound O=C WSFSSNUMVMOOMR-UHFFFAOYSA-N 0.000 description 2
- 229920002527 Glycogen Polymers 0.000 description 2
- 208000004880 Polyuria Diseases 0.000 description 2
- 208000001431 Psychomotor Agitation Diseases 0.000 description 2
- 206010038743 Restlessness Diseases 0.000 description 2
- 208000007271 Substance Withdrawal Syndrome Diseases 0.000 description 2
- 244000269722 Thea sinensis Species 0.000 description 2
- 206010043458 Thirst Diseases 0.000 description 2
- 230000002159 abnormal effect Effects 0.000 description 2
- 230000033228 biological regulation Effects 0.000 description 2
- 238000009534 blood test Methods 0.000 description 2
- 210000004556 brain Anatomy 0.000 description 2
- 230000001684 chronic effect Effects 0.000 description 2
- 235000009508 confectionery Nutrition 0.000 description 2
- 230000000378 dietary effect Effects 0.000 description 2
- 238000002224 dissection Methods 0.000 description 2
- 230000003203 everyday effect Effects 0.000 description 2
- 206010016256 fatigue Diseases 0.000 description 2
- 235000013305 food Nutrition 0.000 description 2
- 229940096919 glycogen Drugs 0.000 description 2
- 238000010562 histological examination Methods 0.000 description 2
- 238000002347 injection Methods 0.000 description 2
- 239000007924 injection Substances 0.000 description 2
- 230000003907 kidney function Effects 0.000 description 2
- 231100001252 long-term toxicity Toxicity 0.000 description 2
- 238000004519 manufacturing process Methods 0.000 description 2
- 231100000682 maximum tolerated dose Toxicity 0.000 description 2
- 210000003205 muscle Anatomy 0.000 description 2
- 235000021590 normal diet Nutrition 0.000 description 2
- 210000004279 orbit Anatomy 0.000 description 2
- 231100000915 pathological change Toxicity 0.000 description 2
- 230000000144 pharmacologic effect Effects 0.000 description 2
- 230000001737 promoting effect Effects 0.000 description 2
- 230000009467 reduction Effects 0.000 description 2
- 230000035945 sensitivity Effects 0.000 description 2
- 229930182837 (R)-adrenaline Natural products 0.000 description 1
- UCTWMZQNUQWSLP-VIFPVBQESA-N (R)-adrenaline Chemical compound CNC[C@H](O)C1=CC=C(O)C(O)=C1 UCTWMZQNUQWSLP-VIFPVBQESA-N 0.000 description 1
- ATADHKWKHYVBTJ-FVGYRXGTSA-N (R)-adrenaline hydrochloride Chemical compound [H+].[Cl-].CNC[C@H](O)C1=CC=C(O)C(O)=C1 ATADHKWKHYVBTJ-FVGYRXGTSA-N 0.000 description 1
- 208000019901 Anxiety disease Diseases 0.000 description 1
- 208000010201 Exanthema Diseases 0.000 description 1
- 206010020710 Hyperphagia Diseases 0.000 description 1
- 208000013016 Hypoglycemia Diseases 0.000 description 1
- 206010022489 Insulin Resistance Diseases 0.000 description 1
- 238000012449 Kunming mouse Methods 0.000 description 1
- 206010054805 Macroangiopathy Diseases 0.000 description 1
- 241000233855 Orchidaceae Species 0.000 description 1
- 102000001253 Protein Kinase Human genes 0.000 description 1
- 241000594182 Sarcophaga sigma Species 0.000 description 1
- 208000005946 Xerostomia Diseases 0.000 description 1
- 230000005856 abnormality Effects 0.000 description 1
- 231100000215 acute (single dose) toxicity testing Toxicity 0.000 description 1
- 239000002671 adjuvant Substances 0.000 description 1
- 229930013930 alkaloid Natural products 0.000 description 1
- 150000003797 alkaloid derivatives Chemical class 0.000 description 1
- 230000003321 amplification Effects 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 238000010171 animal model Methods 0.000 description 1
- 230000001466 anti-adreneric effect Effects 0.000 description 1
- 230000001142 anti-diarrhea Effects 0.000 description 1
- 239000003472 antidiabetic agent Substances 0.000 description 1
- 230000036506 anxiety Effects 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- 230000017531 blood circulation Effects 0.000 description 1
- 238000010241 blood sampling Methods 0.000 description 1
- 230000023852 carbohydrate metabolic process Effects 0.000 description 1
- 235000021256 carbohydrate metabolism Nutrition 0.000 description 1
- 150000001720 carbohydrates Chemical class 0.000 description 1
- 235000014633 carbohydrates Nutrition 0.000 description 1
- 230000001413 cellular effect Effects 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 230000002354 daily effect Effects 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- 238000003748 differential diagnosis Methods 0.000 description 1
- 230000029087 digestion Effects 0.000 description 1
- 239000012153 distilled water Substances 0.000 description 1
- 230000035622 drinking Effects 0.000 description 1
- 230000002526 effect on cardiovascular system Effects 0.000 description 1
- 239000003792 electrolyte Substances 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 229960005139 epinephrine Drugs 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- 201000005884 exanthem Diseases 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 210000001508 eye Anatomy 0.000 description 1
- 235000011389 fruit/vegetable juice Nutrition 0.000 description 1
- 150000004676 glycans Chemical class 0.000 description 1
- 230000004116 glycogenolysis Effects 0.000 description 1
- 230000037308 hair color Effects 0.000 description 1
- 210000003128 head Anatomy 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 230000002607 hemopoietic effect Effects 0.000 description 1
- 230000002440 hepatic effect Effects 0.000 description 1
- 208000021760 high fever Diseases 0.000 description 1
- 230000036039 immunity Effects 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 230000005764 inhibitory process Effects 0.000 description 1
- 230000003914 insulin secretion Effects 0.000 description 1
- 230000002262 irrigation Effects 0.000 description 1
- 238000003973 irrigation Methods 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 230000003908 liver function Effects 0.000 description 1
- 206010025482 malaise Diseases 0.000 description 1
- 239000002398 materia medica Substances 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 230000002175 menstrual effect Effects 0.000 description 1
- 230000002503 metabolic effect Effects 0.000 description 1
- 230000007102 metabolic function Effects 0.000 description 1
- 230000037353 metabolic pathway Effects 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- 230000004089 microcirculation Effects 0.000 description 1
- 230000027939 micturition Effects 0.000 description 1
- 238000003199 nucleic acid amplification method Methods 0.000 description 1
- 230000003119 painkilling effect Effects 0.000 description 1
- 230000008506 pathogenesis Effects 0.000 description 1
- 230000001717 pathogenic effect Effects 0.000 description 1
- 230000007170 pathology Effects 0.000 description 1
- 230000010412 perfusion Effects 0.000 description 1
- 210000003516 pericardium Anatomy 0.000 description 1
- 239000002574 poison Substances 0.000 description 1
- 231100000614 poison Toxicity 0.000 description 1
- 206010036067 polydipsia Diseases 0.000 description 1
- 208000022530 polyphagia Diseases 0.000 description 1
- 229920001282 polysaccharide Polymers 0.000 description 1
- 239000005017 polysaccharide Substances 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 238000012545 processing Methods 0.000 description 1
- 208000037821 progressive disease Diseases 0.000 description 1
- 230000000750 progressive effect Effects 0.000 description 1
- 108060006633 protein kinase Proteins 0.000 description 1
- 238000003127 radioimmunoassay Methods 0.000 description 1
- 206010037844 rash Diseases 0.000 description 1
- 230000008929 regeneration Effects 0.000 description 1
- 238000011069 regeneration method Methods 0.000 description 1
- 230000003014 reinforcing effect Effects 0.000 description 1
- 230000008439 repair process Effects 0.000 description 1
- 208000009146 rhinoscleroma Diseases 0.000 description 1
- 229920006395 saturated elastomer Polymers 0.000 description 1
- 230000028327 secretion Effects 0.000 description 1
- 230000001568 sexual effect Effects 0.000 description 1
- 210000002363 skeletal muscle cell Anatomy 0.000 description 1
- 239000000243 solution Substances 0.000 description 1
- 230000000638 stimulation Effects 0.000 description 1
- 238000005728 strengthening Methods 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 235000019605 sweet taste sensations Nutrition 0.000 description 1
- 238000002560 therapeutic procedure Methods 0.000 description 1
- 230000002110 toxicologic effect Effects 0.000 description 1
- 231100000027 toxicology Toxicity 0.000 description 1
- 238000002562 urinalysis Methods 0.000 description 1
- 210000003462 vein Anatomy 0.000 description 1
- 210000001835 viscera Anatomy 0.000 description 1
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
Description
组别 | N | 血糖值mmol/L(x±SD) | 血清胰岛素值xu/ml(x±SD) |
正常对照组模型对照组消渴丸组本申请颗粒剂高剂量组本申请颗粒剂中剂量组 | 88888 | 7.52±0.5017.91±1.6115.47±1.44**10.11±1.25**△11.8±2.1**△△ | 7.95±0.342.94±0.423.79±0.32*4.48±0.32*△3.85±0.36** |
本申请颗粒剂低剂量组 | 8 | 13.63±2.24**△△ | 3.75±0.47* |
组别 | N | 血糖值mmol/L(x±SD) |
正常对照组模型对照组消渴丸组本申请颗粒剂高剂量组本申请颗粒剂中剂量组 | 1010101010 | 6.23±0.2313.86±0.599.68±0.43**8.29±0.46**△△8.35±0.66**△△ |
本申请颗粒剂低剂量组 | 10 | 8.65±0.75**△ |
组别 | N | 血糖值mmol/L(x±SD) |
正常对照组消渴丸组本申请颗粒剂高剂量组本申请颗粒剂中剂量组 | 10101010 | 6.07±0.265.88±0.645.89±0.215.92±0.24 |
本申请颗粒剂低剂量组 | 10 | 6.02±0.14 |
Claims (3)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CNB2006101386156A CN100496570C (zh) | 2006-11-10 | 2006-11-10 | 一种具有降血糖作用的药物制剂及其制备方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CNB2006101386156A CN100496570C (zh) | 2006-11-10 | 2006-11-10 | 一种具有降血糖作用的药物制剂及其制备方法 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN1947778A true CN1947778A (zh) | 2007-04-18 |
CN100496570C CN100496570C (zh) | 2009-06-10 |
Family
ID=38017466
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CNB2006101386156A Active CN100496570C (zh) | 2006-11-10 | 2006-11-10 | 一种具有降血糖作用的药物制剂及其制备方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN100496570C (zh) |
Cited By (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102488202A (zh) * | 2011-12-13 | 2012-06-13 | 北京阳光一佰生物技术开发有限公司 | 用于糖尿病治疗的药用组合物和制备方法 |
CN103082298A (zh) * | 2013-01-17 | 2013-05-08 | 吉林省中药制剂工程研究中心有限公司 | 一种用于辅助降糖的保健食品及其制备方法 |
CN104223060A (zh) * | 2014-08-25 | 2014-12-24 | 湖州大港天明投资有限公司 | 一种用于降低血糖及增强免疫力的新型保健品 |
CN106072639A (zh) * | 2016-06-27 | 2016-11-09 | 吉林亚泰明星制药有限公司 | 一种辅助降血糖硒片及其制备方法 |
CN106620374A (zh) * | 2015-10-31 | 2017-05-10 | 边海云 | 一种调节2型糖尿病的中药组合物 |
CN109331113A (zh) * | 2018-09-21 | 2019-02-15 | 深圳市红瑞生物科技有限公司 | 辅助治疗宠物糖尿病的处方膏及其制备方法 |
CN113599457A (zh) * | 2021-09-25 | 2021-11-05 | 赣州药食同源健康管理有限公司 | 一种治疗糖尿病的中药组合物及其制备方法 |
-
2006
- 2006-11-10 CN CNB2006101386156A patent/CN100496570C/zh active Active
Cited By (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102488202A (zh) * | 2011-12-13 | 2012-06-13 | 北京阳光一佰生物技术开发有限公司 | 用于糖尿病治疗的药用组合物和制备方法 |
CN102488202B (zh) * | 2011-12-13 | 2013-10-16 | 北京阳光一佰生物技术开发有限公司 | 用于糖尿病治疗的药用组合物和制备方法 |
CN103082298A (zh) * | 2013-01-17 | 2013-05-08 | 吉林省中药制剂工程研究中心有限公司 | 一种用于辅助降糖的保健食品及其制备方法 |
CN103082298B (zh) * | 2013-01-17 | 2014-08-13 | 吉林省中药制剂工程研究中心有限公司 | 一种用于辅助降糖的保健食品及其制备方法 |
CN104223060A (zh) * | 2014-08-25 | 2014-12-24 | 湖州大港天明投资有限公司 | 一种用于降低血糖及增强免疫力的新型保健品 |
CN106620374A (zh) * | 2015-10-31 | 2017-05-10 | 边海云 | 一种调节2型糖尿病的中药组合物 |
CN106072639A (zh) * | 2016-06-27 | 2016-11-09 | 吉林亚泰明星制药有限公司 | 一种辅助降血糖硒片及其制备方法 |
CN109331113A (zh) * | 2018-09-21 | 2019-02-15 | 深圳市红瑞生物科技有限公司 | 辅助治疗宠物糖尿病的处方膏及其制备方法 |
CN113599457A (zh) * | 2021-09-25 | 2021-11-05 | 赣州药食同源健康管理有限公司 | 一种治疗糖尿病的中药组合物及其制备方法 |
Also Published As
Publication number | Publication date |
---|---|
CN100496570C (zh) | 2009-06-10 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN1079027C (zh) | 治疗糖尿病的药物组合物 | |
CN100496570C (zh) | 一种具有降血糖作用的药物制剂及其制备方法 | |
CN101947284B (zh) | 一种治疗糖尿病的中药组合物及其制备方法 | |
CN103285231A (zh) | 一种用于糖尿病辅助治疗的药物组合物及其制法 | |
CN102526479B (zh) | 一种增强免疫力、降血糖功能的保健药物 | |
CN1814167A (zh) | 一种用于糖尿病的保健品 | |
CN102526478A (zh) | 一种增强免疫力、降血糖功能的保健药物配方 | |
CN103417846B (zh) | 一种降糖的中药组合物及其制备方法 | |
CN101347543A (zh) | 一种中药组合物及其制备方法 | |
CN102018852B (zh) | 参连消渴降糖胶囊及制作工艺 | |
CN106362007A (zh) | 含有霍山石斛的具有降糖作用的中药组合物及其制备方法 | |
CN101336965B (zh) | 一种用于改善糖耐量、降低血糖的中成药及其制备方法 | |
CN103599343B (zh) | 一种治疗糖尿病的药物组合物及其制备方法和用途 | |
CN103432420B (zh) | 一种治疗糖尿病的中药组合物及其制备方法和检测方法 | |
CN1066332C (zh) | 复方降糖胶囊 | |
CN103393938B (zh) | 一种降血糖的中药组合物 | |
CN102552677B (zh) | 黄地安消胶囊及其制备方法 | |
CN101590175B (zh) | 一种具有降血糖作用的药物制剂及其制备方法 | |
CN106138900A (zh) | 辅助治疗高血糖和糖尿病并发症的组合物及其应用 | |
CN105168946A (zh) | 一种治疗糖尿病的中药组合物及其用途 | |
CN100398123C (zh) | 一种治疗肾脾两虚挟血瘀型糖尿病的药物 | |
CN105709082A (zh) | 一种治疗糖尿病的中成药消渴茶及其制备方法 | |
CN104815140A (zh) | 一种预防或/和治疗糖尿病的组合物及其制备方法 | |
CN1557378A (zh) | 一种治疗糖尿病的药物 | |
CN100340271C (zh) | 一种治疗糖尿病的降糖药物及其制备方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
EE01 | Entry into force of recordation of patent licensing contract |
Assignee: BEIJING UNIS PHARMACEUTICAL Co.,Ltd. Assignor: BAISHILIKANG MEDICINE SCIENCE AND TECHNOLOGY Co.,Ltd. BEIJING Contract record no.: 2010990000735 Denomination of invention: Hypoglycemic medicine preparation and its prepn. method Granted publication date: 20090610 License type: Exclusive License Open date: 20070418 Record date: 20100909 |
|
DD01 | Delivery of document by public notice |
Addressee: BAISHILIKANG MEDICINE SCIENCE AND TECHNOLOGY Co.,Ltd. BEIJING Document name: Notification to Pay the Fees |
|
DD01 | Delivery of document by public notice | ||
DD01 | Delivery of document by public notice | ||
DD01 | Delivery of document by public notice |
Addressee: BAISHILIKANG MEDICINE SCIENCE AND TECHNOLOGY Co.,Ltd. BEIJING Document name: Notification to Pay the Fees |
|
DD01 | Delivery of document by public notice | ||
DD01 | Delivery of document by public notice |
Addressee: Chen Nan Document name: Notice of patent termination |
|
TR01 | Transfer of patent right | ||
TR01 | Transfer of patent right |
Effective date of registration: 20220715 Address after: 071200 No.1 Tongrentang Road, modern Chinese medicine industrial park, Anguo City, Baoding City, Hebei Province Patentee after: Hebei baixiaodan Pharmaceutical Co.,Ltd. Address before: 102200, room 26, 307 Yongan Road, Changping science and Technology Park, Beijing Patentee before: BAISHILIKANG MEDICINE SCIENCE AND TECHNOLOGY Co.,Ltd. BEIJING |
|
DD01 | Delivery of document by public notice |
Addressee: Chen Nan Document name: Notification of procedure qualification |
|
DD01 | Delivery of document by public notice |